Estrogenic or antiestrogenic therapies for multiple myeloma?

Molecular Cancer

Volumn 6, Issue , 2007, Pages

  Sola, Brigitte ^a   Renoir, Jack Michel ^b,c  

^a UNIVERSITÉ DE CAEN   (France)

^b UNIV PARIS SUD   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

11 [4 [[5 [(4,4,5,5,5 PENTAFLUOROPENTYL)SULFONYL]PENTYL]OXY]PHENYL]ESTRADIOL; 2 METHOXYESTRADIOL; 4 HYDROXYTAMOXIFEN; ANTIESTROGEN; ESTRADIOL; ESTROGEN; FULVESTRANT; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TAMOXIFEN CITRATE; TOREMIFENE; ANTINEOPLASTIC AGENT; CASPASE; CELL CYCLE PROTEIN; DRUG DERIVATIVE; ESTROGEN RECEPTOR;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; B LYMPHOCYTE; CANCER INHIBITION; CANCER SURVIVAL; CELL CYCLE; CELL PROLIFERATION; DISEASE MODEL; DRUG STRUCTURE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MULTIPLE MYELOMA; NONHUMAN; REVIEW; TUMOR XENOGRAFT; CHEMICAL STRUCTURE; DRUG EFFECT; DRUG POTENTIATION; DRUG RESISTANCE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PLASMACYTOMA; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; ESTRADIOL; ESTROGEN ANTAGONISTS; HUMANS; MOLECULAR STRUCTURE; MULTIPLE MYELOMA; NEOVASCULARIZATION, PATHOLOGIC; PLASMACYTOMA; RECEPTORS, ESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SIGNAL TRANSDUCTION;

EID: 36549083019     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-6-59     Document Type: Review

References (49)

1. Hideshima T Bergsagel PL Kuehl WM Anderson KC Advances in biology of multiple myeloma: Clinical applications Blood 2004, 104:607-618. 10.1182/ blood-2004-01-0037 15090448
2. Bommert K Bargou RC Stühmer T Signalling and survival pathways in multiple myeloma Eur J Cancer 2006, 42:1574-1580. 10.1016/ j.ejca.2005.12.026 16797970
3. Mooberry SL New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent Curr Opin Oncol 2003, 15:425-430. 10.1097/00001622-200311000-00004 14624224
4. Chauhan D Catley L Hideshima T Li G Leblanc R Gupta D Sattier M Richardson P Schlossman RL Podar K Weller E Munshi N Anderson KC 2-methoxyestradiol overcomes drug resistance in multiple myeloma Blood 2002, 100:2187-2194. 10.1182/blood-2002-02-0376 12200384
5. Dingli D Timm M Russell SJ Witzig TE Rajkumar SV Promising preclinical activity of 2-methoxyestradiol in multiple myeloma Clin Cancer Res 2002, 8:3948-3954. 12473611
6. Chauhan D Li G Auclair D Hideshima T Richardson P Podar K Mitsiades N Mitsiades C Li C Kim RS Munshi N Chen LB Wong W Anderson KC Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arrays Blood 2003, 101:3606-3614. 10.1182/blood-2002-10-3146 12480690
7. Wang LH Yang XY Mihalic K Xiao W Li D Farrar WL Activation of estrogen receptor blocks interleukin-6-inducible cell growth of human multiple myeloma involving molecular cross-talk between estrogen receptor and STAT3 mediated by co-regulator PIAS3 J Biol Chem 2001, 276:31839-31844. 10.1074/jbc.M105185200 11429412
8. Bharti AC Shishodia S Reuben JM Weber D Alexanian R Raj-Vadhan S Estrov Z Talpaz M Aggarwal BB Nuclear factor-kappa B and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis Blood 2004, 103:3175-3184. 10.1182/blood-2003-06-2151 15070700
9. Chatterjee M Stühmer T Herrmann P Bommert K Dörken B Bargou RC Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells Blood 2004, 104:3712-3721. 10.1182/ blood-2004-04-1670 15297310
10. Otsuki T Yamada O Kurebayashi J Moriya T Sakaguchi H Kunisue H Yata K Uno M Yawata Y Ueki A Estrogen receptors in human myeloma cells Cancer Res 2000, 60:1434-1441. 10728710
11. Gauduchon J Gouilleux F Maillard S Marsaud V Renoir J-M Sola B 4-hydroxytamoxifen inhibits proliferation of multiple myeloma cells in vitro through down-regulation of c-Myc, up-regulation of p27Kip1, and modulation of Bcl-2 family members Clin Cancer Res 2005, 11:2345-2354. 10.1158/1078-0432.CCR-04-1668 15788686
12. Treon SP Teoh G Urashima M Ogata A Chauhan D Webb IJ Anderson KA Anti-estrogens induce apoptosis of multiple myeloma cells Blood 1998, 92:1749-1757. 9716605
13. Jordan VC SERMs: Meeting the promise of multifunctional medicines J Natl Cancer Inst 2007, 99:350-356. 10.1093/jnci/djk062 17341726
14. Olivier S Close P Castermans E de Leval L Tabruyn S Chariot A Malaise M Merville M-P Bours V Franchimont N Raloxifene-induced myeloma cell apoptosis: A study of nuclear factor-κB inhibition and gene expression signature Mol Pharmacol 2006, 69:1615-1623. 10.1124/ mol.105.020479 16497877
15. Howell A Pure oestrogen antagonists for the treatment of advanced breast cancer Endocr Relat Cancer 2006, 13:689-706. 10.1677/erc.1.00846 16954425
16. Maillars S Gauduchon J Marsaud V Gouilleux F Connault E Opolon P Fattal E Sola B Renoir J-M Improved antitumoral properties of pure antiestrogen RU 58668-loaded liposomes in multiple myeloma J Steroid Biochem Mol Biol 2006, 100:67-78. 10.1016/j.jsbmb.2006.03.008 16753295
17. Renoir JM Stella B Ameller T Connault E Opolon P Marsaud V Improved anti-tumoral capacity of mixed and pure anti-oestrogens in breast cancer cell xenografts after their administration by entrapment in colloidal nanosystems J Steroid Biochem Mol Biol 2006, 102:114-127. 10.1016/ j.jsbmb.2006.09.001 17056251
18. Ascenzi P Bocedi A Marino M Structure-function relationship of estrogen receptor alpha and beta: Impact on human health Mol Aspects Med 2006, 27:299-402. 10.1016/j.mam.2006.07.001 16914190
19. Maillard S Ameller T Gauduchon J Gougelet A Gouilleux F Legrand P Marsaud V Fattal E Sola B Renoir J-M Innovative drug delivery nanosystems improve the anti-tumor activity in vitro and in vivo of anti-estrogens in human breast cancer and multiple myeloma J Steroid Biochem Mol Biol 2005, 94:111-121. 10.1016/j.jsbmb.2004.12.023 15862956
20. Shim G-J Gherman D Kim H-J Omoto Y Iwase H Bouton D Levente Kis L Thulin Andersson C Warner M Gustafsson J-Å Differential expression of oestrogen receptors in human secondary lymphoid tissues J Pathol 2006, 208:408-414. 10.1002/path.1883 16294372
21. LaVallee TM Zhan XH Herbstritt CJ Kough EC Green SJ Pribluda VS 2-methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors α and β Cancer Res 2002, 62:3691-3697. 12097276
22. Hartman J Lindberg K Morani A Inzunza J Ström A Gustafsson J-Å Estrogen receptor β inhibits angiogenesis and growth of T47D breast cancer xenografts Cancer Res 2006, 66:11207-11213. 10.1158/ 0008-5472.CAN-06-0017 17145865
23. Obrero M Yu DV Shapiro DJ Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen-induced programmed cell death J Biol Chem 2002, 277:45695-45703. 10.1074/jbc.M208092200 12244117
24. Frasor J Stossi F Danes JM Komm B Lyttle CR Katzenellenbogen BS Selective estrogen receptor modulators: Discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells Cancer Res 2004, 64:1522-1533. 10.1158/ 0008-5472.CAN-03-3326 14973112
25. Mandlekar S Yu R Yan TH Kong AN Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-uinduced apoptosis of human breast cancer cells Cancer Res 2000, 60:5995-6000. 11085519
26. Smolnikar K Löffek S Schulz T Michna H Diel P Treatment with the pure antiestrogen faslodex (ICI 182780) induces tumor necrosis factor receptor 1 (TNFR1) expression in MCF-7 breast cancer cells Breast Cancer Res Treat 2000, 63:249-259. 10.1023/A:1006490416408 11110059
27. Zheng A Kallio A Härkönen P Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen Endocrinology 2007, 148:2764-2777. 10.1210/en.2006-1269 17363451
28. Kallio A Zheng A Dahlund J Heiskanen KM Härkönen P Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells Apoptosis 2005, 10:1395-1410. 10.1007/s10495-005-2137-z 16215679
29. Levin ER Integration of the extranuclear and nuclear actions of estrogen Mol Endocrinol 2005, 19:1951-1959. 1249516 15705661 10.1210/me.2004-0390
30. Márquez DC Pietras RJ Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells Oncogene 2001, 20:5420-5430. 10.1038/sj.onc.1204729 11571639
31. Razandi M Pedram A Merchenthaler I Greene GL Levin ER Plasma membrane estrogen receptors exists and function as dimers Mol Endocrinol 2004, 18:2854-2865. 10.1210/me.2004-0115 15231873
32. Pedram A Razandai M Levin ER Nature of functional estrogen receptors at the plasma membrane Mol Endocrinol 2006, 20:1996-2009. 10.1210/ me.2005-0525 16645038
33. Heberden C Reine F Grosse B Henry C Zagar Y Chaumaz G Lieberherr M Detection of a raft-located estrogen receptor-like protein distinct from ER alpha Int J Biochem Cell Biol 2006, 38:376-391. 10.1016/ j.biocel.2005.09.006 16263324
34. Ponzielli R Katz S Barsyte-Lovejoy D Penn LZ Cancer therapeutics: targeting the dark site of Myc Eur J Cancer 2005, 41:2485-2501. 10.1016/ j.ejca.2005.08.017 16243519
35. Carroll JS Swarbrick A Musgrove EA Sutherland RL Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens Cancer Res 2002, 62:3126-3131. 12036924
36. Cariou S Donovan JC Flanagan WM Milic A Bhattachara N Slingerland JM Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells Proc Natl Acad Sci USA 2000, 97:9042-9046. 16818 10908655 10.1073/ pnas.160016897
37. Mukherjee S Conrad SE c-Myc suppresses p21WAF1/CIP1 expression during estrogen signalling and antiestrogen resistance in human breast cancer cells J Biol Chem 2005, 208:17617-17625.
38. Carroll JS Lynch DK Swarbrick A Renoir J-M Sarcevic B Daly RJ Musgrove EA Sutherland RL p27Kip1 induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells Cancer Res 2003, 63:4322-4326. 12907598
39. Thiantanawat A Long BJ Brodie AM Signaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens Cancer Res 2003, 63:8037-8050. 14633737
40. Alas S Bonavida B Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis Clin Cancer Res 2003, 9:316-326. 12538484
41. Quintanilla-Martinez L Kremer M Specht K Calzada-Wack J Nathrath M Schaich R Hofler H Fend F Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events Am J Pathol 2003, 162:1449-1461. 1851203 12707028
42. Chauhan D Uchiyama H Akbarali Y Urashima M Yamamoto K Libermann TA Anderson KC Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B Blood 1996, 87:1104-1112. 8562936
43. Catlett-Falcone R Landowski TH Oshiro MM Turkson J Levitzki A Savino R Ciliberto G Moscinski L Fernández-Luna JL Nuñez G Dalton WS Jove R Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells Immunity 1999, 10:105-115. 10.1016/ S1074-7613(00)80011-4 10023775
44. Ogawa M Nishiura T Oritani K Yoshida H Yoshimura M Okajima Y Ishikawa J Hashimoto K Matsumura I Tomiyama Y Masuzawa Y Cytokines prevent dexamethasone-induced apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in a new multiple myeloma cell line Cancer Res 2000, 60:4262-4269. 10945640
45. Hideshima T Akiyama M Hayashi T Richardson P Schlossman R Chauhan D Anderson KC Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieu Blood 2003, 101:703-705. 10.1182/ blood-2002-06-1874 12393542
46. Fassas AB-T Rapoport AP Bolaños-Meade J Shanholtz C Cottler-Fox M Tricot G Tamoxifen-based treatment induces clinically meaningful responses in multiple myeloma patients with relapsing disease after autotransplantation Leuk Lymphoma 2001, 42:1323-1328. 10.1080/ 10428190127507 11911415
47. PubChem Compound http://www.ncbi.nlm.nih.gov/sites/entrez?db=pccompound
48. Mitsiades CS Treon SP Mitsiades N Shima Y Richardson P Schlossman R Hideshima T Anderson KC TRAIL/Apo2L ligand selectively induces apoptosis and overcomes resistance in multiple myeloma: Therapeutic implications Blood 2001, 98:795-804. 10.1182/blood.V98.3.795 11468181
49. Drexler HG The leukemia-lymphoma cell line Facts Book Academic Press 2001.